Grifols SA convenes its Annual General Shareholders’ Meeting today, June 18, 2026. Shareholders will vote on key board resolutions during this second-call meeting.
The board seeks authorization to increase share capital by up to 50%. This capital expansion would occur over the next five years.
Shareholders will also decide whether to authorize a pursuit of admission to the US Nasdaq market. This potential listing represents a major strategic move for the Spanish healthcare company.
The agenda also includes the re-election of several directors.